
Edelman appoints Kajsa Wilhelmsson
pharmafile | April 8, 2010 | Appointment | Medical Communications | Edelman, appointment, medical communications
Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs.
She will be based in the company’s Brussels office and moves to the agency from European think-thank Health Consumer Powerhouse, where she was instrumental in growing the group from a Swedish start-up to a global force in health consumer information.
Wilhelmsson has more than 20 years of experience in the political, media and corporate environments and prior to her work at HCP, Wilhelmsson worked for Baxter, HELA (the Swedish trade association for private healthcare providers) and Swedish Nuclear Fuel.
Laurent Chokoualé Datou, general manager of Edelman Brussels, said: “Kajsa has an unrivalled profile and compelling credentials in a range of health-related European regulatory, public affairs and advocacy issues. I am thrilled to enlist her as part of our team and look forward to her making a strong contribution to our business.”
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






